New study from Japan found after reclassifying COVID to a lower alert level, reported infections dropped sharply due to reduced testing, but wastewater continued detecting high viral loads, revealing invisible community spread including asymptomatic cases missed by testing alone.
This is the kind of thing that occasionally crosses your mind while hospitalized for 5 days, but there’s not much you can do but trust your own N95. medicalxpress.com/news/2026-01-s…
I woke up to being Quoted by Blue Maga blaming President Trump. This study analyzed changes in 2023. In the United States, we stopped mandatory reporting then downgraded it in 2024. Who was President when these policies went into effect?
You people are a societal plague.
If you’re Red Maga, the vaccine time travels. It’s responsible for things that occurred in 2020-21.
If you’re Blue Maga, the virus time travels. It was bad in 2020, went away 2021-2024, and now it’s back again.
Gastroenterology as a specialty should be obliterated. Not all GI Drs. are bad, but the practice only looks for things to rule out rather than problem solving. The only reason I’m home from the hospital is because of the Emergency Room MD, an Internist and the nursing staff.
When I got to the ER it was so bad that I could not give an honest recount of that day, but the ER Dr. got me in for scans almost immediately, put me on heavy duty pain injections and said I should be admitted - zero chance that I could go home. Friday was a complete blur.
I came to on Saturday and my dad showed up, wearing an actual mask, so I assumed I had passed on into the IACC nothing new afterlife, but no.
Finally a really nice internist prescribed an Rx called Carafate, which is a GI med to treat ulcers, and she continued my pain med.
The National Bureau of Economic Research analyzed death certificates and wage data, concluding workers substantially underestimate the COVID mortality risk compared to other job related mortality (Value of Statistical Life), likely due to being uninformed and job market pressure.
Peer reviewed & published in 2025, Journal of Risk & Uncertainty:
Not sure you can access the working paper w/o an institutional email, so here’s a key excerpt stating this is a first, highly relevant and new-future data will be used for economic policy. link.springer.com/article/10.100…
The NBER published this paper last year as well, which is directly correlated. Over $200 Billion (likely upwards of $220B) has been saved in future Social Security payments due to excess COVID deaths just between 2020-2023, which improved SSA financial health.
A new CDC study published in JAMA today, shows COVID is still killing a substantial number of Americans, with over 100K deaths annually between 2022-2024.
‘Although the Public Health Emergency ended, this study suggests it remains a major driver of mortality among older adults.’
We did it Joe! We killed hundreds of thousands of people after the orange guy left and blue maga doesn’t give a shit because they’re red maga in blue hats. bu.edu/articles/2022/…
Meta analysis of 429 studies and 2M people found a 36% pooled prevalence of LongCOVID globally.
29% rate among non-hospitalized with memory issues, muscle weakness, dyspnea, joint pain the most common symptoms. Stratified by year, prevalence was still 34% in 2024 v 38% in 2021.
Alt text didn’t save;
More Than One-Third of Individuals With COVID-19
Experience Long COVID
Jessica Nye, PhD |
Systematic review and meta-analysis published in Open Forum Infectious Diseases reported a pooled prevalence of long COVID as 36% worldwide.
A total of 429 studies
There are several healthcare industry reports showing various sales trends with data driven factors provided.
The latest is loss of taste and smell (anosmia) expecting to reach $4.1B by 2034 with increasing LongCOVID cases and viral infections (COVID) being the major catalysts.
Even for those without login credentials, the summary repeatedly explains that North America makes up 42% of this trend and they use terms like “rising post COVID” and “surge post infection (COVID)”.
These data drive the push to spend on new diagnostics and therapeutics.
Research based on this continued growth (if you want to call it that) is driving collaboration between universities, AI and pharmaceutical.
Seems odd that if LongCOVID rates were “decreasing” and COVID was no biggie, you’d see this type of market strategy and spending.
Just had an appointment with one of my Doctors and we’re going to try something new on top of my antiviral experiment. It should be covered by insurance so I said “well that’s a relief for once,” to which he replied;
“LongCOVID is very expensive my friend, I’d try to avoid it.”
For reference, after we finished the pharmacy called and said this med would cost $340 with insurance, or $300 without. My double experiment is costing more than most luxury cars, except I don’t drive a luxury car, I’m just trying to get back to normal.
So here’s the rub;
Letting millions of people get infected as much as they like, leads to million of people developing new health issues, most of which will be chronic, thus putting money directly into big pharma’s and Uncle Sam’s pocket.
There will be no operation Warp Speed to deal with this.